Portal de Periódicos da CAPES

Diabetic Foot Ulcers: Current Advances in Antimicrobial Therapies and Emerging Treatments

2019; Multidisciplinary Digital Publishing Institute; Volume: 8; Issue: 4 Linguagem: Inglês

10.3390/antibiotics8040193

2079-6382

Jesus Manuel Ramirez-Acuña, Sergio Andres Cardenas-Cadena, Pedro A Marquez-Salas, Idalia Garza‐Veloz, Aurelio Perez-Favila, Miguel A. Cid-Báez, Virginia Flores‐Morales, Margarita L. Martínez‐Fierro,

Pressure Ulcer Prevention and Management

Diabetic foot ulcers (DFUs) are very important diabetes-related lesions that can lead to serious physical consequences like amputations of limbs and equally severe social, psychological, and economic outcomes. It is reported that up to 25% of patients with diabetes develop a DFU in their lifetime, and more than half of them become infected. Therefore, it is essential to manage infection and ulcer recovery to prevent negatives outcomes. The available information plays a significant role in keeping both physicians and patients aware of the emerging therapies against DFUs. The purpose of this review is to compile the currently available approaches in the managing and treatment of DFUs, including molecular and regenerative medicine, antimicrobial and energy-based therapies, and the use of plant extracts, antimicrobial peptides, growth factors, ozone, devices, and nano-medicine, to offer an overview of the assessment of this condition.